ClinicaliQ Trial Snapshot
- Exercise Intervention as an Adjunct to Medical Therapy in Newly Diagnosed Patients With Pulmonary Arterial Hypertension — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT07366879.
- Intervention being tested: A structured exercise programme initiated early after pulmonary arterial hypertension (PAH) diagnosis, delivered alongside standard medical therapy, to evaluate improvements in physical fitness, mental wellbeing, and potentially disease progression compared to medical therapy alone.
- Patient eligibility overview: Newly diagnosed patients with pulmonary arterial hypertension who are commencing or recently commenced on medical therapy; typically requires stable clinical status and ability to participate in supervised exercise programmes.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The goal of this clinical trial is to learn if an exercise programme started shortly after diagnosis improves the fitness and mental wellbeing of patients with pulmonary hypertenion over and above medication alone. It will also learn about whether extra support can help patients keep up with exercise in the long term. The main questions it aims to answer are: * Doe exercise improve how far patients can walk over six minutes * Does exercise improve quality of life scores * Does exercise improve mental health scores * Does extra…
Eligibility Snapshot
- : * Aged 18-years-old and above * Diagnosed with pulmonary hypertension (group I and non-operable group IV) by right heart catheterisation showing: * a baseline mean pulmonary artery pressure >20mmHg * pulmonary vascular resistance >2 Wood Units * pulmonary capillary wedge pressure
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.